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Background: Major clinical gaps impede the evidence-based treatment of chronic   obstructive 
pulmonary disease (COPD) in the primary care setting. Studies are needed to measure the 
effectiveness of continuing medical education (CME) on improving physician competency and 
performance toward evidence-based COPD care.
Methods: Between September 26, 2009 and December 12, 2009, 769 primary care physicians 
participated in a series of 12 regional, live, interactive, case-based, multiformat, half-day CME 
programs on COPD. A subgroup of randomly selected participants (n = 50) and demographically 
matched nonparticipants (n = 50) completed surveys that included case vignettes, a validated 
tool for measuring physician performance in clinical practice. Cohen’s d was used to calcu-
late the magnitude of difference between participants and nonparticipants in the delivery of 
evidence-based care.
Results: Physicians who participated in CME programs were 50% more likely to provide 
evidence-based COPD care than physicians who did not participate. Compared with nonpar-
ticipants, participating physicians were more likely to recognize COPD correctly in a patient 
presenting with dyspnea (74% versus 94%, P = 0.007), recognize that women may have a 
greater susceptibility than men to the toxic effects of smoking (54% versus 90%, P , 0.001), 
and identify the mechanisms of action of emerging therapies (33% versus 65%, P = 0.003).
Conclusion: Physicians who participated in a half-day regional CME program on COPD 
diagnosis, staging, and treatment were significantly more likely than nonparticipants to deliver 
evidence-based COPD care. With multiformat, interactive, focused educational interventions, 
physicians can make diagnostic and therapeutic choices in the primary care setting that align 
more closely with current guidelines and clinical evidence in COPD management.
Keywords: COPD, continuing medical education, practice patterns, outcomes measurement, 
case vignettes, effect size
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and mor-
bidity worldwide. Approximately 16 million Americans are currently diagnosed with 
COPD, while another 14 million may be affected but remain undiagnosed.1 Each year, 
COPD is responsible for more than eight million physician office and hospital outpatient 
visits, 1.5 million emergency department visits, and 726,000   hospitalizations.2 COPD 
is the fourth leading cause of death in the US, and is projected to become third by the International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
298
Drexel et al
year 2020 if drastic changes in diagnosis and management 
are not implemented.3
Despite these striking statistics, COPD remains poorly 
managed in the primary care setting. One major barrier to 
  better patient outcomes is the underdiagnosis of COPD, 
which delays treatment and leaves symptoms unmanaged. 
COPD is highly prevalent in primary care; approximately one 
in four adults aged 40 years or older with known risk factors 
for COPD, including tobacco use and self-reported symptoms 
of chronic bronchitis, have airway obstruction consistent with 
a diagnosis of COPD.1 Yet primary care physicians will less 
commonly consider and pursue the diagnosis of COPD than 
other diagnoses with fewer symptoms, such as hyperten-
sion and diabetes.4 Moreover, only one in four primary care 
physicians adhere to guideline-recommended spirometry and 
medication use more than 90% of the time.5
According to the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) guidelines, COPD is both a prevent-
able and treatable disease, and increased focus on accurate 
diagnosis, staging, and management may reduce the overall 
burden of the disease.6 Continuing medical education (CME) 
programs that address the inadequacies of COPD care may 
improve physician competency in providing guideline-
directed COPD care. The American College of Chest Phy-
sicians has called for more research on the effectiveness of 
CME initiatives in improving physician competency and 
performance toward evidence-based care.7 The underlying 
rationale for CME is that providers who are educated about 
the latest standards of care will make more informed diag-
nostic and treatment decisions, resulting in improved patient 
outcomes.8 To date, the CME literature suggests that the 
most effective strategies contain several design elements, 
such as a rigorous and accurate assessment of need, use of 
active and varied learning approaches, and an evidence-based 
curriculum that focuses on overcoming barriers to change.9 
Additionally, a change in physician practice is more likely 
with interventions that are multifaceted, interactive, and 
consistent with the perceived needs of the learner.10
In September 2009, we implemented a live, highly inten-
sive, case-based educational initiative called “Improving 
COPD Patient Outcomes: Breaking Down the Barriers to 
Optimal Care”. This CME initiative consisted of a series of 
12 regional half-day meetings designed to address existing 
knowledge and practice gaps in the management of COPD. 
The objective of this communication is to report the impact 
of this educational initiative on participants’ knowledge and 
competency in the guideline-based diagnosis, staging, and 
management of COPD.
Materials and methods
Between September 26, 2009, and December 12, 2009, 12 
regional, live, interactive, case-based, multiformat, half-day 
CME programs were held on the topic of COPD. The pro-
gram learning objectives and content were developed by a 
faculty panel of three leading experts in the management of 
COPD. Specifically, the program was designed to increase 
the ability of primary care providers to:
•	 Describe the demographics of COPD burden and explain 
the impact of patient comorbid conditions on COPD 
outcomes and management
•	 Obtain reliable office spirometry results through proper 
patient education and coaching
•	 Diagnose, stage, and manage a patient with COPD with 
a combination of management strategies, including risk 
reduction, pharmacologic, and nonpharmacologic inter-
ventions as per guideline recommendations
•	 List emerging therapies for management of COPD
•	 Implement patient-oriented strategies to optimize adher-
ence and improve outcomes.
To accomplish these educational objectives, the   half-day 
program incorporated a mix of proven adult-learning 
formats,9 including a series of short (25–30-minute) didactic 
lectures, with several audience response system questions 
designed to promote faculty-learner interaction. To enhance 
their patient education skills, participants watched a video 
about the correct use of inhaler devices. Physician learners 
also participated in two small-group workshops. One work-
shop focused on a detailed case discussion, with challenges 
related to diagnosis, staging, initial treatment, and manage-
ment of COPD exacerbations, and follow-up care. In the 
second workshop, learners participated in hands-on demon-
strations of handheld spirometers, and engaged in active role 
playing of spirometry coaching, reading, and interpretation 
to reinforce accurate office spirometry use.
Measurement of effectiveness
The effectiveness of the educational intervention was mea-
sured using a survey comprised of evidence-based case 
vignettes and questions about physician confidence in the 
optimal management of patients with COPD. The case 
vignettes were framed around several key measurement 
indicators, which are evidence-based statements that outline 
the health care performance expectations associated with the 
content of an educational activity. The measurement indica-
tors identified for this program and used to develop the case 
vignette survey were concentrated in the areas of COPD 
pathophysiology, diagnosis, and management (Table 1).International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Table 1 effectiveness of educational intervention: measurement indicators
Aspects of COPD management Measurement indicators
Pathophysiology and natural history •   In COPD, the ongoing inflammatory process leads to enlargement of the alveolar spaces, fibrosis, and 
destruction of the lung parenchyma; these changes increase with disease severity and persist on smoking 
cessation2,32,33
• Cumulative exposure to noxious particles (including cigarette smoke) is the key risk factor for COPD10
•   Compared with men having COPD, women with COPD have greater susceptibility to toxic effects of 
smoking.34
Diagnosis and staging •   A diagnosis of COPD should be considered in any patient who has cough, sputum production, dyspnea, 
and/or a history of exposure to risk factors; the diagnosis is confirmed by spirometry6,35–37
•   A consensus statement by the national Lung health education Program recommends the widespread 
use of office spirometry by primary care providers for patients $45 years old who smoke cigarettes6,5–37
•   A good test requires a good effort on the part of the patient and enthusiastic coaching by the 
technician; for spirometry to be of value, the FVC test must be performed correctly38
• staging requires knowing FeV1 and FVC and understanding how to use them to stage a patient6
• Patients with FeV1 ,40% have severe COPD.6
Treatment • Current pharmacotherapies do not change the natural history of COPD
•   COPD needs to be treated early, and regular treatment with long-acting bronchodilators is an effective 
and convenient maintenance treatment6
•   For patients with severe COPD who have repeated exacerbations, glucocorticosteroids should be 
added to the treatment regimen6
•   Patients may be on a short-acting bronchodilator, a long-acting bronchodilator, a combination product, 
and glucocorticosteroids6
• Unintentional nonadherence may reflect poor comprehension of the treatment regimen39
•   nicotine dependence might function as a barrier to smoking cessation; nicotine dependence, in particular 
withdrawal, was related to a high number of quit attempts and to remaining a current smoker40
•   A number of Phase III clinical trials have assessed the potential utility of PDe4 inhibitors in the treatment 
of COPD.41–43
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in the first second; FVC, forced vital capacity; PDE4, phosphodiesterase 4.
The case vignettes were presented (in survey format) to 
program participants and a demographically similar group 
of nonparticipants. The vignettes were designed to assess 
whether the diagnostic and therapeutic choices of the partici-
pants were consistent with clinical evidence presented in the 
content of the educational activity. The case vignettes were 
also used to assess whether practice choices of participants 
were different from practice choices of nonparticipants.
Additional survey items were included to assess   barriers 
to the optimal management of COPD. Respondents were 
asked to rate the severity of five potential barriers to optimal 
COPD management on a scale of 1 (lowest significance) to 
10 (highest significance). Respondents were also asked to 
rate their level of familiarity with four aspects of COPD 
management on a scale of 1 (least familiar) to 10 (most 
familiar).
All surveys were field-tested for content validity and 
revised based on field testing comments/suggestions prior 
to implementation. Finalized surveys were distributed to 
participants immediately following each of the 12 regional 
half-day programs. Survey responses were also collected 
from a demographically similar group of nonparticipants 
from the American Medical Association database, matched 
by degree, specialty, practice setting, and number of patients 
with COPD seen per week, via email.
Data analysis
Data were analyzed using the Statistical Package for Social 
Sciences (SPSS 17.0, SPSS Inc, Chicago, IL). Data were first 
arrayed using frequencies, and t-tests were then used to test for 
differences between the mean evidence-based responses of the 
participants and the nonparticipants. Differences between 
the two groups were considered significant if P # 0.10. 
The educational effect size was calculated to determine the 
amount of difference in treatment choices between the CME 
participants and nonparticipants, using a method previously 
published by Colliver et al.11 Effect size is calculated using 
the Cohen’s d formula, and expressed as a percentage of 
nonoverlap between participants and nonparticipants, or the 
percentage achieved by participants that was not reflected in 
the evidence-based responses of nonparticipants. Any posi-
tive difference between the two groups where the content is 
relevant to the participants’ patient populations demonstrates 
an important potential educational impact.
Effect size analysis was performed using physician data 
only. Based on total attendance, preliminary power analysis International Journal of COPD 2011:6
Table 2 Baseline demographics of effectiveness subgroup
Characteristic Participants 
(n = 50)
Nonparticipants 
(n = 50)
Patients seen per week  
with COPD
11 15
Years in practice 28 years 24 years
specialty
  Family practice 50% 52%
  Internal medicine 50% 48%
Degree
  MD/DO 100% 100%
Present employment
  solo practice 45% 38%
  group practice 31% 58%
  Medical school 0% 2%
  health-management  
  organization
0% 2%
  government 25% 0%
Practice location
  Urban 40.4% 30.0%
  suburban 55.3% 52.0%
  rural  4.3% 18.0%
Abbreviation: COPD, chronic obstructive pulmonary disease.
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with dyspnea on exertion (94% versus 74%, P = 0.007, 
Table 3, Case 1).
Clinicians who participated in the educational interven-
tion also showed an improved understanding of smoking as 
a leading risk factor for the development and progression of 
COPD. Participants were more likely than nonparticipants 
to recognize correctly that women may have a greater sus-
ceptibility than men to the toxic effects of smoking (90% 
versus 54%, P , 0.001, Table 5, Case 3). Participants were 
also more likely to recognize the importance of encouraging 
the spouse of a COPD patient to quit smoking (92% versus 
82%, Table 3, Case 1).
spirometry use
Familiarity with spirometry testing and interpretation was 
generally low among both participants and nonparticipants. 
Participants reported a significantly lower mean level of 
familiarity than nonparticipants (5.9 versus 6.9, P = 0.014). 
More participants than nonparticipants described themselves 
as not at all familiar (13% versus 4%) or somewhat familiar 
(62% versus 54%) with spirometry, whereas fewer reported 
that they were completely familiar (25% versus 44%) with 
the procedure (Figure 1). Participants’ answers to case study 
questions showed a nonsignificant trend toward a greater 
willingness to use office-based spirometry in the initial 
assessment of suspected COPD (98% versus 90%, Table 3) 
and in the long-term monitoring of confirmed COPD (86% 
versus 76%, Table 4) compared with nonparticipants.
COPD staging
Participants were twice as likely as nonparticipants to report 
complete familiarity with the GOLD guidelines (28% versus 
14%). Participants’ greater self-reported knowledge and 
confidence in applying the GOLD guidelines were reflected 
in the case vignettes, where participants were more likely 
than nonparticipants to determine disease severity correctly 
(58% versus 44%, Table 4, Case 2) according to GOLD 
severity criteria.
COPD management and emerging 
therapies
Participants and nonparticipants were equally likely to select 
guideline-recommended pharmacotherapy for COPD patients 
with repeated exacerbations (64% versus 66%, Table 4, Case 2). 
Participants were more likely than nonparticipants (61% versus 
50%) to select a guideline-recommended strategy for main-
tenance therapy (Table 5, Case 3). Participants were more 
likely than nonparticipants to report complete familiarity with 
demonstrated that sample data from 50 participants and 50 
nonparticipants were needed to demonstrate a significant 
(P # 0.10) 30% difference in educational index between 
the physician groups.
Results
Baseline characteristics
A total of 769 health care providers participated in the edu-
cational program, including 699 physicians, 13 nurses, and 
57 other practitioners. Participants reported seeing a total 
of at least 8459 patients with COPD per week within their 
clinical practices.
A total of 146 effectiveness surveys were collected from 
769 participants (response rate, 19%), and 53 surveys were 
collected from 160 nonparticipating physicians contacted by 
email (response rate, 33%). A random subgroup of partici-
pants (n = 50) who completed the effectiveness survey were 
matched with nonparticipants (n = 50) according to clinical 
specialty, years in practice, and treatment setting (Table 2). 
Participant and nonparticipant responses to the survey ques-
tions are summarized in Tables 3–5.
Pathophysiology and natural  
history of COPD
When asked about the underlying pathophysiology of 
COPD, a greater proportion of participants than nonpar-
ticipants recognized alveolar destruction as the most likely 
etiology for shortness of breath in a patient presenting International Journal of COPD 2011:6
Table 3 Case 1 survey results
Case 1: A 51-year-old woman presents for her annual visit. In reviewing her recent health, she reports mild shortness of breath when climbing a flight of stairs. 
Her past medical history is significant only for hypothyroidism (well controlled with thyroid replacement therapy). There is no history of early heart disease in 
her family. Her father died of lung cancer. The patient smoked two packs per day for 10 years but quit more than five years ago. Her husband (also a patient of 
yours) continues to smoke. she works as a bank teller and until this past year was moderately active (walking 30 minutes three times per week).
Case questions  
and responses*
Participants 
(n = 50)
Nonparticipants 
(n = 50)
P value
n % n %
Based on the patient’s presentation, what is the  
most likely etiology for her shortness of breath?
Alveolar destruction* 46 93.9% 37 74.0% 0.007
Muscular deconditioning 2 4.1% 8 16.0%
Synovial inflammation 1 2.0% 3 6.0%
Increased left ventricular filling pressure 0 0.0% 2 4.0%
Total respondents 49 100.0% 50 100.0%
What is the most appropriate 
next step to diagnose her dyspnea?
repeat thyroid-stimulating hormone test 1 2.0% 1 2.0%
spirometry* 48 98.0% 45 90.0% 0.204
refer for cardiac catheterization 0 0.0% 2 4.0%
Watchful waiting 0 0.0% 2 4.0%
Total respondents 49 100.0% 50 100.0%
What intervention would you recommend  
to improve her current condition?
Advise that she take a daily aspirin 0 0.0% 1 2.0%
Advise that she take an iron supplement 0 0.0% 0 0.0%
Advise that she get her husband to quit smoking* 46 92.0% 41 82.0% 0.137
refer her to physical therapy 4 8.0% 8 16.0%
Total respondents 50 100.0% 50 100.0%
Notes: *An evidence-based answer. not all respondents answered every question.
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  emerging therapies for COPD (21% versus 4%, Figure 1) and 
were more likely to identify correctly the mechanisms of action 
of emerging therapies (33% versus 65%, P = 0.003, Table 5).
Barriers to guideline-recommended care
When potential barriers to COPD management were evaluated, 
participants rated “patient lack of adherence to smoking ces-
sation recommendations” as a more severe barrier to optimal 
COPD care than did nonparticipants (9.2 versus 8.6, P = 0.025, 
Figure 2). In addition, participants assigned a lower mean score 
to “lack of clarity about staging COPD severity” than nonpar-
ticipants (4.8 versus 5.6, P = 0.083, Figure 2). Participants were 
nearly twice as likely as nonparticipants to describe this potential 
barrier as not at all significant (31.9% versus 16.0%).
Regarding the use of spirometry as a potential barrier to 
COPD management, participants assigned a higher mean 
severity score to “difficulty in obtaining spirometry results” 
than nonparticipants (5.4 versus 4.4, P = 0.029, Figure 2). 
More participants than nonparticipants described obtaining 
spirometry results as a very significant barrier (27% versus 
12%), whereas fewer participants reported spirometry as not 
significant (25% versus 40%).
educational impact of the program
Effect size analysis showed a 50% nonoverlapping difference 
in the evidence-based clinical choices made by participants 
and nonparticipants. This represents a 50% increased like-
lihood that clinicians who participated in the “Improving 
COPD Patient Outcomes: Breaking Down the Barriers to 
Optimal Care” program were making choices in response to 
case vignettes based on clinical evidence. Based on the aver-
age number of patients with COPD seen weekly by the 769 
health care providers who attended the educational activity, 
these data indicate that at least 8459 COPD patients are 50% 
more likely to receive evidence-based care than those seen by 
health care providers who did not participate in the activity.
Discussion
Clinicians who participated in the program described here 
demonstrated improved knowledge and competency in a vari-
ety of areas related to the management of COPD, including 
etiology and risk factors, disease staging,   guideline-directed 
patient management, and emerging treatment options. 
Furthermore, participating clinicians were 50% more 
likely than nonparticipants to provide evidence-based and International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Table 4 Case 2 survey results
Case 2: A 68-year-old man who recently moved to the area presents to the urgent care clinic with an acute complaint of productive cough. he has a 
20-pack year history of smoking but quit five years ago. He was started last year on an albuterol inhaler by his prior physician. On further review, he has 
had no fevers, sweats, weight loss, nausea, or vomiting. he reports that for the past year he typically begins each morning with productive cough but is 
fine the rest of the day. This pattern is somewhat worse over the past two weeks, with his cough persisting for most of the morning. On examination 
he is a thin man in no acute distress. he is afebrile, breathing comfortably, with decreased breath sounds but no focal wheezes or areas of consolidation 
on pulmonary examination. The rest of his examination is within normal limits.
Case questions and responses* Participants  
(n = 50)
Nonparticipants  
(n = 50)
P value
n % n %
What would be your next step in the management of this patient?
Prescribe a macrolide or cephalosporin antibiotic 16 32.7% 21 42.0%
Initiate a 21-day tapered oral glucocorticoid regimen 3 6.1% 4 8.0%
Initiate a long-acting beta2-agonist* 30 61.2% 25 50.0% 0.261
Admit the patient to the hospital 0 0.0% 0 0.0%
Total respondents 49 100.0% 50 100.0%
Which of the following studies would you use in his  
long-term management?
Chest x-ray 4 8.0% 8 16.0%
high-resolution chest CT 3 6.0% 3 6.0%
spirometry* 43 86.0% 38 76.0% 0.202
sleep study 0 0.0% 1 2.0%
Total respondents 50 100.0% 50 100.0%
Case 2 (Continued): The patient comes to see you two weeks later. his chest x-ray obtained at his urgent care visit was normal. his sleep study was 
negative. his spirometry results from last week indicated that his FeV1 was ,40% predicted, FeV1/FVC ,0.70. he is feeling much better and has stopped 
taking his inhalers.
Which of the following strategies would be most likely to improve  
the patient’s adherence?
Provide in clear detail the results of recent trials showing mortality  
trends and benefits of therapy
19 38.8% 16 32.0%
Identify the patient’s preferences about different therapeutic choices 8 16.3% 19 38.0%
Assess the patient’s comprehension of different treatment options* 14 28.6% 10 20.0% 0.320
refer the patient to pulmonary rehabilitation 8 16.3% 5 10.0%
Total respondents 49 100.0% 50 100.0%
Based on the gOLD criteria, what severity stage is this patient?
gOLD stage 1 – mild 3 6.0% 4 8.0%
gOLD stage 2 – moderate 18 36.0% 24 48.0%
gOLD stage 3 – severe* 29 58.0% 22 44.0% 0.161
gOLD stage 4 – very severe 0 0.0% 0 0.0%
Total respondents 50 100.0% 50 100.0%
Notes: *An evidence-based answer. not all respondents answered every question.
Abbreviations: CT, computed tomography; FeV1, forced expiratory volume in the first second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive 
Pulmonary Diseases.
  guideline-driven care. Specific areas of patient care that were 
most affected by attending the activity included recognizing 
gender differences in susceptibility to the toxic effects of 
smoking, using spirometry in the assessment and monitoring 
of patients with COPD, identifying stage of COPD based on 
the FEV1 value, and maintenance therapy.
Considerable research on CME has focused on the 
ability of specific educational interventions to improve 
provider knowledge, competence, and ultimately, patient 
outcomes. In a 2007 meta-analysis of CME interventions, 
the mean effect size of various interventions was 28%, 
with greater effect sizes observed from active learning 
methods than from passive educational interventions 
(33% versus 20%).12 By comparison, the effect size of the 
“Improving COPD Patient Outcomes: Breaking Down the 
Barriers to Optimal Care” program was 50%, much higher 
than the average effect size across the spectrum of CME 
interventions.
Our large effect size may stem from the multiple modes of 
delivery. In 2009, the American College of Chest Physicians 
released a series of evidence-based guidelines on the devel-
opment of effective CME programs.7,9,13–15 Consistent with 
principles of adult learning theory, the American   College 
of Chest Physicians emphasized the importance of using International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Table 5 Case 3 survey results
Case 3: A 69-year-old woman presents for a regularly scheduled follow-up visit. she has type 2 diabetes, hypertension, and COPD. spirometry results 
obtained two years ago showed an FeV1/FVC ratio , 0.7 and an FeV1 60% predicted. A sleep study the following year was normal. she has had three 
COPD exacerbations in the past two years characterized by periods of increased sputum production. her medical regimen currently consists of 
metformin, lisinopril, as needed albuterol, and daily salmeterol. 
Case questions and responses* Participants 
(n = 50)
Nonparticipants 
(n = 50)
P value
n % n %
What would you recommend as the next therapeutic step to 
improve COPD control in this patient?
Prescribe home oxygen therapy 1 2.0% 1 2.0%
Add a short-acting inhaled anticholinergic agent (ipratropium) 17 34.0% 16 32.0%
Add an inhaled glucocorticosteroid* 32 64.0% 33 66.0% 0.834
refer for surgical evaluation 0 0.0% 0 0.0%
Total respondents 50 100.0% 50 100.0%
Compared with men, women with COPD tend to have:
Less airway hyperresponsiveness 0 0.0% 11 22.0%
Better health-related quality of life 0 0.0% 3 6.0%
greater susceptibility to the toxic effects of smoking* 44 89.8% 27 54.0% ,0.001
Increased probability of diagnosis on initial presentation 5 10.2% 9 18.0%
Total respondents 49 100.0% 50 100.0%
Which medication classes have been shown to change the natural 
history of COPD?
Corticosteroid 11 35.5% 20 42.6%
Corticosteroid + bronchodilator 8 25.8% 11 23.4%
Bronchodilator 5 16.1% 9 19.1%
Antibiotic + corticosteroid 0 0.0% 1 2.1%
Phosphodiesterase 4 inhibitor 2 6.5% 0 0.0%
none* 5 16.1% 6 12.8% 0.746
Total respondents 31 100.0% 47 100.0%
For which of the following inflammatory molecular targets in COPD  
is there an agent in Phase III development?
PPAr-γ 8 20.0% 10 20.8%
PDe4* 26 65.0% 16 33.3% 0.003
TnF α 4 10.0% 7 14.6%
IL-8 2 5.0% 15 31.3%
Total respondents 40 100.0% 48 100.0%
Notes: *An evidence-based answer. not all respondents answered every question. 
Abbreviations: COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in the first second; FVC, forced vital capacity; IL, interleukin; PDE4, 
phosphodiesterase 4; PPAr, peroxisome proliferation activated receptor; TnF, tumor necrosis factor.
multiple instructional techniques to effect positive change 
on physician knowledge, practice performance, and clini-
cal outcomes.7,9,13–15 The program incorporated many of the 
educational formats recommended by the American College 
of Chest Physicians, including case-based learning,   audience 
response system, lectures, hands-on demonstrations, dis-
cussion groups, and role playing.9 The half-day program 
emphasized faculty-learner interactions via discussion of 
practice preferences and responses to knowledge-based and 
competency-based audience response system questions, with 
ample time for open discussion. The small-group workshops 
provided learners with additional opportunities for interac-
tion and faculty feedback regarding clinical decision-making 
in the management of COPD. With this approach, this 
  multimodal educational activity engaged 769 physicians and 
potentially influenced the care of nearly 8500 patients.
Results from our study show that participation in the 
program improved physician knowledge of the underlying 
pathophysiology of COPD, as well as gender differences 
as a risk factor for COPD. The ability of CME activities to 
increase physician knowledge is well documented in the 
CME literature. Bruno et al found that participation in a 
live peer-to-peer CME activity increased pulmonologists’ 
knowledge about the diagnosis and management of idiopathic 
pulmonary fibrosis.16 Dimor et al reported immediate gains 
in physician knowledge, as measured by changes in response 
patterns before and after a 1.5-day immersion course on 
sleep quality.17International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Figure 2 Barriers to the management of chronic obstructive pulmonary disease. Mean barrier severity score on a scale of 1 (lowest significance) to 10 (highest significance).
Non-participants (n = 50) 43%
25%6 2% 13%
43%4 %
Completely familiar Somewhat familiar Not familiar
Participants (n = 50)
Figure 1 Familiarity with spirometry interpretation. Participants and nonparticipants 
were asked to rate their level of familiarity with spirometry interpretation on a scale 
of 1 (least familiar) to 10 (most familiar). responses were analyzed by mean ranking 
and by proportion of responses indicating that physicians were not at all familiar 
(1–3),  somewhat  familiar  (4–7),  or  extremely  familiar  (8–10)  with  spirometry 
interpretation.
Response patterns to the case vignettes indicate that 
the physician participants increased their competency in 
two important areas, ie, staging COPD severity on the 
basis of spirometry data and managing COPD patients 
with pharmacologic and nonpharmacologic   interventions. 
Within the evolving CME landscape, activities have 
shifted in focus in recent years from increasing provider 
knowledge to improving competency. Outcomes research 
to document gains in competency and health care delivery 
have followed suit. Peterson et al showed that participa-
tion in a two-day course resulted in a significant increase 
in self-assessed   competency.18 Participants who reported 
substantial improvements in competency were more likely 
than nonparticipants to make appropriate evidence-based 
management decisions.18
In our study, the quality of education index of 50% 
in our study indicates a high likelihood that primary care 
providers who participated in the educational intervention 
will provide evidence-based and guideline-driven care for 
patients with COPD. Although the relationship between 
physician competency and clinical behavior is not well under-
stood, studies suggest that enhancing provider competency 
translates into an increase in physicians’ performance in 
providing evidence-based and guideline-based care. In turn, 
improved physician performance can lead to improved patient 
care and patient outcomes. Cabana et al reported improved 
asthma symptoms and decreased health care utilization 
among patients whose physicians had attended two interac-
tive seminar sessions on asthma care that included short 
lectures, case discussions, and video modeling of patient 
communication techniques.19
Ulrik et al20 evaluated the effects of an intensive series 
of educational programs for primary care providers and 
their staff on the clinical management of COPD. After one 
year, COPD education was associated with improvements 
in several indicators of guideline adherence, including a 
significant increase in the use of spirometry (P , 0.001), International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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documentation of smoking status (P , 0.01), counseling 
regarding smoking cessation, inhaler technique, physical 
activity, and   rehabilitation (P , 0.01), and a significant shift 
toward guideline-directed and stage-specific pharmacologic 
management of COPD (P , 0.001).20
Persistent clinical gaps
Our survey identified several persistent barriers to optimal 
COPD management that may serve as appropriate targets for 
additional education. Clinicians in both study groups ranked 
“lack of adherence to smoking cessation   recommendations” 
as the greatest of several barriers to optimal COPD 
  management. Participants assigned this barrier a higher score 
than nonparticipants, suggesting that the educational activity 
successfully reinforced the importance of smoking cessation 
as a key element of COPD management. Additional educa-
tion in this area may empower clinicians to overcome this 
barrier to optimal COPD care successfully.
Our results are consistent with those of several   others 
showing practice gaps related to the incorporation of 
spirometry into the diagnosis and management of COPD 
in primary care.21–24 However, compared with nonpar-
ticipants, participating physicians considered “difficulty in 
obtaining spirometry results” to be a more severe barrier. 
  Furthermore, participants described themselves as less 
familiar with spirometry interpretation than nonparticipants. 
These   findings contrast with results from the Case 2 vignette 
(Table 4) indicating increased competency in performing 
spirometry and interpreting spirometric results. These data 
appear contradictory, but may in fact highlight the effec-
tiveness of CME in providing a “reality check” about the 
practical challenges of performing and interpreting results 
from office spirometry tests. After experiencing hands-on 
demonstrations of office spirometers, role playing the task 
of spirometry coach, and attempting to interpret real-time 
spirometry results, participants were more likely to recognize 
and report gaps in their own competency with the correct 
use and interpretation of spirometry. Our findings illustrate 
the importance of identifying learner-reported competency 
gaps, such as spirometry use and interpretation, as targets 
for additional educational intervention.
study limitations
In today’s CME environment, greater emphasis has been 
given to measuring higher level educational outcomes. The 
effect of physician education on patient outcomes is the 
ultimate endpoint, but was not measured in this   assessment. 
While direct application of learning into practice was 
not assessed, the methodology in this study assumes that 
improvements in knowledge, competency, and performance 
ultimately translate into higher quality care and improved 
patient outcomes. Our outcomes methodology relies on com-
paring responses to a series of case vignettes from physicians 
who participated in a CME activity with those obtained from 
a comparable group of physicians who did not receive the 
same education.25 Other methods for assessing the effect of 
physician education have been reported in the CME literature. 
One option involves chart abstraction. This method is limited 
by the potential for recording bias due to time constraints on 
outpatient visits and a cumbersome process of adjustment 
for case-mix variation.26 Evaluation of deidentified claims 
data is another method for measuring change in physician 
competence. While this methodology can accurately report 
impact on patient care, it is highly dependent on variable 
insurance reporting systems, which may delay or alter data 
collection.27 Case vignettes have gained considerable sup-
port for their value in predicting physician practice patterns. 
Results from recent research studies demonstrate that case 
vignettes, when compared with chart review and standardized 
patients, are a valid and comprehensive method to measure 
a physician’s process of care in actual clinical practice.26,28 
Furthermore, case vignettes are more cost-effective and less 
invasive than other means of measurement.26
Assessing the participants prior to the activity, and 
comparing preactivity results with those obtained after 
the activity may also provide an objective measure of 
educational impact. We prefered the methodology of 
comparing data from participants and matched nonpar-
ticipants because pre- and post-assessments are usually 
associated with a high attrition rate, which would com-
plicate the analysis. Our methodology may be limited by 
an imperfectly matched control group, because although 
it was demographically matched to the participant group, 
other potential key confounders, such as previous COPD 
training and attitudes towards COPD management, were 
not taken into consideration.
In our study, participants completed the case vignette 
  surveys directly after the program, thereby capturing 
  immediate improvements in knowledge, competency, and 
intention to change practice behavior. Surveying partici-
pants weeks or months following an educational activity is 
favored as a means for assessing long-term retention, as well 
as to evaluate performance change that occurred after the 
physicians returned to practice. Some studies have shown a 
decline in learning retention with follow-up testing of CME 
programs,29,30 whereas others have shown a gain in retention International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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(eg, due to the ability of learners to transfer new knowledge 
into practice over time).31 In the present study, repeat follow-up 
testing of participants may have shown a different level of 
educational impact. Nevertheless, our data project an impact 
on physician behavior and strongly support the benefits of 
CME for improving the delivery of guideline-recommended 
patient care. However, given that our participants were a self-
selected group of primary care providers with an interest in 
COPD, the educational effectiveness of this program may not 
be generalizable to all primary care providers.
Conclusion
Participation in a half-day, highly interactive CME activity 
is associated with increased physician knowledge in the 
management of COPD, as well as increased likelihood for 
patients to receive evidence-based care from participating 
physicians. Our findings also identified opportunities for 
additional improvement in certain aspects of care, including 
spirometry use and smoking cessation.
With focused educational interventions, physicians can 
make diagnostic and therapeutic choices that align more 
closely with current guidelines and clinical evidence in 
COPD management. These findings strengthen the rationale 
for interactive CME programs to improve provider knowledge 
and competency, and demonstrate the ability to document the 
educational effectiveness of CME initiatives.
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